 | Up a level |
Burmester, G., Rubbert-Roth, A., Cantagrel, A., Hall, S., Leszczynski, P., Feldman, D., Rangaraj, M., Roane, G., Ludivico, C., Mysler, E., Nash, P., Wells, C., Bennett, M. and Vranic, I (2014). THE EFFICACY AND SAFETY OF TOCILIZUMAB SUBCUTANEOUS VERSUS TOCILIZUMAB INTRAVENOUS, IN COMBINATION WITH TRADITIONAL DMARDS IN PATIENTS WITH RA AT 49 WEEKS (SUMMACTA) (ENCORE). Intern. Med. J., 44. S. 25 - 27. HOBOKEN: WILEY-BLACKWELL. ISSN 1445-5994
Burmester, G., Rubbert-Roth, A., Cantagrel, A., Hall, S., Leszczynski, P., Feldman, D., Rangaraj, M. J., Roane, G., Ludivico, C., Mysler, E., Bennett, M. J., Rowell, L. and Bao, M. (2014). THE EFFICACY AND SAFETY OF SUBCUTANEOUS TOCILIZUMAB VERSUS INTRAVENOUS TOCILIZUMAB IN COMBINATION WITH TRADITIONAL DMARDS IN PATIENTS WITH RA AT WEEK 97 (SUMMACTA). Ann. Rheum. Dis., 73. S. 499 - 501. LONDON: BMJ PUBLISHING GROUP. ISSN 1468-2060